Webcast: Sales Agreement with AB Vista
Avivagen’s CEO, Kym Anthony, discusses the recent sales agreement with AB Vista that was announced on Friday, October 1st, 2021. Listen or read the transcript below. Transcript Operator Good day ladies and gentlemen. Welcome everyone to Avivagen’s analyst and investor call to discuss their landmark deal with AB Vista. As a reminder, today’s conference […]
C-Suite Interview with Avivagen (VIVXF) CEO Kym Anthony
Noble Capital Markets research on Avivagen is published under ticker symbols VIVXF and VIV:CA. The price target is in USD and based on ticker symbol VIVXF. Avivagen Inc is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to […]
Avivagen Discusses Significant Purchase Orders for OxC-beta™ Livestock with The Stock Day Podcast
The Stock Day Podcast welcomed Avivagen (VIVXF)(“the Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. CEO of the Company, Kym Anthony, joined Stock Day host Everett Jolly.
Avivagen CEO Interviewed on C-Suite At The Open
Kym Anthony, CEO of Avivagen, was recently interviewed by Karoline Hunter, Head of TSX Company Services at the TMX group. The interview covered the company story and gives a look ahead at the future of Avivagen’s OxC-BetaTM. The interview also covers Immune Priming, its powerful anti-inflammatory effect, and its efficacy in improving Gut Health.
Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy
The Stock Day Podcast welcomed Avivagen Inc. (CHEXF)(“the Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. CEO of Avivagen Inc., Kym Anthony, joined Stock Day host Everett Jolly.
Avivagen CEO Interviewed By Proactive Investors
Avivagen CEO Kym Anthony was interviewed by Christine Corrado about superbugs, antibiotics in livestock feed, and how Avivagen’s discovery of OxC-beta can help to address these issues.
Featured Interview: CEO Kym Anthony of Avivagen, Inc. (OTCPink: CHEXF)
CEO Kym Anthony of Avivagen, Inc. (OTCPink: CHEXF)(TSX.v:VIV), returns to Stock Day to discuss recent trials, milestones to achieve in the coming year, and growing revenues in 2019.
Avivagen CEO Interviewed at VICTAM Asia 2018 Conference
Avivagen recently debuted at the VICTAM ASIA 2018 Conference in Bangkok, Thailand.
CEO Kym Anthony Interviewed by Uptick
CEO Kym Anthony was interviewed by the penny stock news and trends podcast, Uptick Newswire. I think if people keep their eyes on the size of the prize, [they’ll see] the livestock market is in the billions of dollars; our share of that would be in the hundreds of millions if we roll out successfully. […]
